Method verification and quantification of nimetazepam in erimin 5 using reverse phase HPLC

Erimin 5 is a brand name of nimetazepam that can be found in the form of tablets and powder. Nimetazepam is the active ingredient of Erimin 5. The nimetazepam is one the benzodiazepines listed in the Dangerous Drugs Act ( 1952). The Erimin 5 is used to treat for short term severe insomnia in patient...

Full description

Bibliographic Details
Main Author: Bukhary, Aiman Arif Mohamed
Format: Monograph
Language:English
Published: Universiti Sains Malaysia 2016
Subjects:
Online Access:http://eprints.usm.my/62518/
http://eprints.usm.my/62518/1/AIMAN%20ARIF%20BIN%20MOHAMED%20BUKHARY%20-%20e.pdf
_version_ 1848885008901603328
author Bukhary, Aiman Arif Mohamed
author_facet Bukhary, Aiman Arif Mohamed
author_sort Bukhary, Aiman Arif Mohamed
building USM Institutional Repository
collection Online Access
description Erimin 5 is a brand name of nimetazepam that can be found in the form of tablets and powder. Nimetazepam is the active ingredient of Erimin 5. The nimetazepam is one the benzodiazepines listed in the Dangerous Drugs Act ( 1952). The Erimin 5 is used to treat for short term severe insomnia in patients who had difficulties in falling asleep or maintaining sleep. This drug is commonly abused in Malaysia since its appearance in illicit drug markets in middle I 980's due to it wide availability and low price. Many samples of Erimin 5 were submitted to the forensic laboratories for analysis. Prior to the analysis, standard methods shall be verified if there is a change in operators, instruments, chemicals, or site of analysis. In this research, the method verification of a validated reverse phase high perfonnance liquid chromatography (RP-HPLC) method was conducted by looking at five parameters namely selectivity and specificity, linearity, limit of detection (LOD), accuracy by recovery, and precision. The results were as follows, selectivity: a distinct narrow peak of nimetazepam, limit of detection (LOD): 0.002 mg/mL, linearity: R2 value was I, accuracy: more than 80% for 0.1 mg/mL, 0.2 mg/mL, and 0.3 mg/mL, precision: coefficient variations (CV) were less than 20% for inter-day and intra-day for both 0.1 mg/mL nimetazepam and quality control samples. In conclusion, the HPLC method intended for the detection of nimetazepam met the parameters required for routine drug analysis in forensic laboratories.
first_indexed 2025-11-15T19:15:46Z
format Monograph
id usm-62518
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T19:15:46Z
publishDate 2016
publisher Universiti Sains Malaysia
recordtype eprints
repository_type Digital Repository
spelling usm-625182025-07-21T03:58:52Z http://eprints.usm.my/62518/ Method verification and quantification of nimetazepam in erimin 5 using reverse phase HPLC Bukhary, Aiman Arif Mohamed R Medicine (General) Erimin 5 is a brand name of nimetazepam that can be found in the form of tablets and powder. Nimetazepam is the active ingredient of Erimin 5. The nimetazepam is one the benzodiazepines listed in the Dangerous Drugs Act ( 1952). The Erimin 5 is used to treat for short term severe insomnia in patients who had difficulties in falling asleep or maintaining sleep. This drug is commonly abused in Malaysia since its appearance in illicit drug markets in middle I 980's due to it wide availability and low price. Many samples of Erimin 5 were submitted to the forensic laboratories for analysis. Prior to the analysis, standard methods shall be verified if there is a change in operators, instruments, chemicals, or site of analysis. In this research, the method verification of a validated reverse phase high perfonnance liquid chromatography (RP-HPLC) method was conducted by looking at five parameters namely selectivity and specificity, linearity, limit of detection (LOD), accuracy by recovery, and precision. The results were as follows, selectivity: a distinct narrow peak of nimetazepam, limit of detection (LOD): 0.002 mg/mL, linearity: R2 value was I, accuracy: more than 80% for 0.1 mg/mL, 0.2 mg/mL, and 0.3 mg/mL, precision: coefficient variations (CV) were less than 20% for inter-day and intra-day for both 0.1 mg/mL nimetazepam and quality control samples. In conclusion, the HPLC method intended for the detection of nimetazepam met the parameters required for routine drug analysis in forensic laboratories. Universiti Sains Malaysia 2016 Monograph NonPeerReviewed application/pdf en http://eprints.usm.my/62518/1/AIMAN%20ARIF%20BIN%20MOHAMED%20BUKHARY%20-%20e.pdf Bukhary, Aiman Arif Mohamed (2016) Method verification and quantification of nimetazepam in erimin 5 using reverse phase HPLC. Project Report. Universiti Sains Malaysia. (Submitted)
spellingShingle R Medicine (General)
Bukhary, Aiman Arif Mohamed
Method verification and quantification of nimetazepam in erimin 5 using reverse phase HPLC
title Method verification and quantification of nimetazepam in erimin 5 using reverse phase HPLC
title_full Method verification and quantification of nimetazepam in erimin 5 using reverse phase HPLC
title_fullStr Method verification and quantification of nimetazepam in erimin 5 using reverse phase HPLC
title_full_unstemmed Method verification and quantification of nimetazepam in erimin 5 using reverse phase HPLC
title_short Method verification and quantification of nimetazepam in erimin 5 using reverse phase HPLC
title_sort method verification and quantification of nimetazepam in erimin 5 using reverse phase hplc
topic R Medicine (General)
url http://eprints.usm.my/62518/
http://eprints.usm.my/62518/1/AIMAN%20ARIF%20BIN%20MOHAMED%20BUKHARY%20-%20e.pdf